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ABSTRACT 
Kv1.3 channels play a pivotal role in the activation and migration of T lymphocytes.  These 
functions are accompanied by the channels’ polarization which is essential for associated 
downstream events.  However, the mechanisms that govern the membrane movement of Kv1.3 
channels remain unclear. F-actin polymerization occurs concomitantly to channels’ polarization 
implicating the actin cytoskeleton in this process. Here we show that cortactin, a factor initiating 
actin network, controls the membrane mobilization of Kv1.3 channels.  FRAP with EGFP-tagged 
Kv1.3 channels demonstrate that knocking down cortactin decreases the actin-based 
immobilization of the channels. Using various deletion and mutation constructs, we show that 
 http://www.molbiolcell.org/content/suppl/2015/03/02/mbc.E14-07-1195v1.DC1.html
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the SH3 motif of Kv1.3 mediates the channel immobilization.  Proximity ligation assays indicate 
that deletion or mutation of the SH3 motif also disrupts interaction of the channel with cortactin. 
In T lymphocytes, the interaction between HS1 (the cortactin homologue) and Kv1.3 occurs at 
the immune synapse and requires the channel’s C-terminal domain. These results show that actin 
dynamics regulates the membrane motility of Kv1.3 channels. They also provide evidence that 
the SH3 motif of the channel and cortactin play key roles in this process. 
 
INTRODUCTION 
The ability of membrane proteins to compartmentalize in specific membrane domains is 
essential to cell function. This is particularly true for T lymphocytes which polarize when they 
migrate and activate. Activation of T lymphocytes is initiated by the encounter with antigen 
presenting cells (APC). The physical interaction between the T cell and the APC leads to a 
cascade of cellular events including polarization of the T cell with accumulation of cell surface 
proteins, intracellular organelles, and signaling molecules at the T-APC contact site, forming a 
highly organized signaling zone known as the immunological synapse (IS) (Cahalan and 
Chandy, 2009; Kummerow et al., 2009).  The movement of specific cell surface proteins into the 
IS is necessary for proper activation of the T cell as disruption of the IS architecture can lead to 
either T cell hypo- or hyper activation (Mossman et al., 2005).   
One important cell surface protein that localizes to the IS during T cell activation is the 
voltage-gated potassium channel, Kv1.3.  Kv1.3 channels play an essential role in the T cell 
activation process by regulating the electrochemical driving force for Ca
2+
 influx and generation 




]i) necessary for downstream transcription factor 
activation and T cell clonal expansion (Wulff et al., 2003; Hu et al., 2013). Indeed, blocking 
Kv1.3 channel’s current suppresses Ca2+ influx and T cell activation (Cahalan and Chandy, 
2009; Hajdu et al., 2013). Furthermore, improper localization of Kv1.3 to the IS leads to altered 
[Ca
2+
]i dynamics, and has been associated with aberrant T cell signaling in systemic lupus 
erythematosus (SLE) (Nicolaou et al., 2007; Nicolaou et al., 2009; Nicolaou et al., 2010). The 
exact mechanisms governing the movement of Kv1.3 to the IS and the channel’s accumulation at 
this site are not fully understood, although it has been shown that membrane-incorporated Kv1.3 
proteins move into the IS via lateral movement along the plane of the plasma membrane 
(Nicolaou et al., 2009). The processes by which proteins gather at the IS are in general still 
poorly understood. Synapse organization has often been said to involve the phenomenon of 
“diffusion trapping” which depends on both passive (molecular diffusion) and active 
mechanisms (involving the actin cytoskeleton) (Favier et al., 2001; Douglass and Vale, 2005; 
Davis and van der Merwe, 2006; Dushek et al., 2008). The actin cytoskeleton has been 
implicated in the transport and trapping at the IS of various proteins including the TCR (Dustin, 
2007; Dushek et al., 2008; Babich et al., 2012). Several studies reported that association of 
channels of the Kv1 family to actin is guaranteed by adapter proteins which possess actin-
binding domains: PDZ-binding proteins, like hDlg1 (disc large 1), and cortactin. The binding of 
cortactin and PDZ proteins to Kv channels occurs at the  C-terminal region of the channel with 
cortactin binding associated with a 19 amino acid long sequence in Kv1.2 channels  and PDZ 
binding occurring at a TDV amino acid motif in Kv1.3 and Kv1.4 channels  (Imamura et al., 
2002; Marks and Fadool, 2007; Doczi et al., 2011).  Additionally, the Src homology 3 (SH3) 
domain, which can be found on cortactin, PDZ proteins, and Kv channels, may also play a role in 
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these proteins’ interactions as SH3 binding domains have been found to be integral in PDZ 
protein induced clustering of Kv1.4, and have been associated with modulation of Kv1.3 current 
(Shin et al., 2000; Marks and Fadool, 2007). T cells express the cortactin analog HS1 
(hematopoietic lineage cell-specific protein 1) and the PDZ binding proteins hDlg1and PSD-95 
which are able to form complexes with actin and bind multiple Kv channel isoforms (Daly, 2004; 
Xavier et al., 2004; Carrizosa et al., 2009). HS1 in T cells was shown to be necessary for the 
accumulation of F-actin to the IS, and for the development of the appropriate signaling post IS 
formation  (Gomez et al., 2006).  Furthermore, C-terminal truncation of Kv1.3 or knockdown of 
PSD-95 in Jurkat T cells has been recently reported to decrease the amount of Kv1.3 channels in 
the IS at early time points (Szilágyi et al., 2013). Thus, it is possible that the interaction with 
actin drives and stabilizes Kv1.3 compartmentalization to the IS. Nevertheless, the involvement 
of the aforementioned proteins in actin-mediated Kv1.3 membrane motility remains unclear.  In 
the present study, wild-type Kv1.3 channels and C-terminal mutated Kv1.3 channels lacking 
cortactin, SH3 or PDZ binding motifs were investigated to further elucidate the mechanisms and 
the molecular requirements for Kv1.3 lateral membrane mobility and localization. 
 
RESULTS 
Co-localization of Kv1.3 channels with cortactin  
It was described that cortactin has a Kv channel binding sequence and binds to various ion 
channels (Hattan et al., 2002; Tian et al., 2006; Williams et al., 2007; Cheng et al., 2011; 
Ilatovskaya et al., 2011; Herrmann et al., 2012). Thus, to reveal whether Kv1.3 channels co-
localize with cortactin, we performed immunocytochemistry experiments using a HEK-293 cell 
line which stably expresses FLAG-Kv1.3 channels. We labeled the plasma membrane localized 
Kv1.3 channels on fixed, but non-permabilized, cells followed by the intracellular staining of 
cortactin. Confocal images shown in Figure 1 revealed that the fluorescent signals of labeled 
membrane Kv1.3 channels (green) and cortactin (red) are highly overlapping which indicates 
that these proteins exist in close proximity to each other and predicts a possible interaction 
between them.  
Cortactin/SH3/PDZ-binding site mutants of Kv1.3  
Since confocal images suggested a possible association between Kv1.3 and cortactin, we 
compared the C-terminal end of Kv1.2 to that of Kv1.3 to determine whether the cortactin 
binding sequence identified in Kv1.2 was also present in Kv1.3 (Hattan et al., 2002). A similar 
19-amino-acid domain was identified in Kv1.3 (Fig. 2A). Moreover, SH3 (PxxP) and a PDZ 
binding (FTDV) motifs are also positioned on the C-terminal of Kv1.3 downstream of the 
putative cortactin binding site (Fig. 2B). Based on this analysis, we designed several mutants of 
Kv1.3 with altered C terminus. Sequential truncation of the C terminus resulted in constructs 
without any recognition sites (putative cortactin, SH3, PDZ: 1), only with putative cortactin-
binding motif (2; for sake of clarity from now on “putative cortactin-binding” is defined by 
simply “cortactin-binding”) and with cortactin- and SH3-binding domain (3); and with 
mutation of few amino acids we obtained full length Kv1.3 channels without SH3-binding 
domain (SH3) or PDZ-binding sequence (PDZ) (Figure 2C). A C-terminal truncated mutant 
previously designed, C, was also utilized (Szilagyi et al., 2013). The effective neutralization of 
the SH3 domain in this Kv1.3 construct has been previously confirmed (Marks and Fadool, 
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2007). The inability of the PDZ Kv1.3 mutant to bind PDZ proteins was established by 
immunoprecipation (Supplemental Figure S1). Cells were co-transfected with myc-Dlg1 and 
either EGFP-tagged WT or PDZ Kv1.3 clones. After immunopreciptation of Dlg1, Kv1.3 was 
detected only in the cells transfected with wild-type (WT) Kv1.3. All these mutants can thus be 
used to obtain information on the site of Kv1.3 interaction with cortactin, and clarify whether 
other adaptor proteins (hDlg1, PSD95) are required for this linkage. 
 
Electrophysiology of mutant channels 
The deletion of the C-terminus of Kv1.x channels may lead to loss-of-function and inappropriate 
sorting of the proteins (Zhu et al., 2003; Zhu et al., 2007). Consequently, electrophysiological 
experiments were performed to verify the appropriate membrane targeting and assembly of each 
Kv1.3 mutant channel. Kv1.3 variants were transiently transfected into HEK-293 cells, and K
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currents were recorded in outside-out patches from cells expressing EGFP-tagged channels. 
Kinetic and equilibrium parameters of Kv1.3 channel’s gating for 1, 2, 3, SH3 and PDZ 
mutants and WT constructs were compared. The biophysical properties of C was determined 
before (Szilágyi et al., 2013). No differences were found between C and WT Kv1.3 (Szilágyi et 
al., 2013). As shown in Figure 3A, the current traces obtained upon a 2-s long depolarization 
from a patch expressing WT and 1 plasmids are almost identical (not all mutants shown for 
clear visibility). To obtain time constant characteristics for inactivation the declining part of the 
current traces was fitted with one-exponential function (see Materials and Methods). Figure 3B 
demonstrates that none of the mutations introduced into Kv1.3 protein modifies the time constant 
of inactivation (i) which was in ms for WT: 219  22 (n=8), 1: 233  36 (n=5), 2: 244  33 
(n=7), 3: 249  20 (n=8), SH3: 257  22 (n=8), PDZ: 211  34 (n=11)  (p=0.831). 
Afterwards the steady-state parameters of the voltage-dependence of activation, which describes 
the opening probability of the channel at a certain membrane potential, were determined for all 
channel constructs: normalized whole-cell conductance was plotted against test potential and 
Boltzmann functions were fitted to the data points (only shown for WT and 1 in Fig. 3C). We 
found that both half-maximal activation voltage (V1/2) and slope factor (k) were not statistically 
different for any mutants of Kv1.3 (k was for WT: 12.2 ± 1.2 mV (n=5), 1: 10.1 ± 1 mV (n=4) 
2: 11.3 ± 1.1 mV (n=6), 3: 11.6 ± 0.4 mV (n=6) SH3: 10.6 ± 0.4 mV (n=5) PDZ: and 13.2 
± 1.2 mV (n=7) p=0.285; V1/2 was for WT: -20.8 ± 3.5 mV (n=5), 1: -22.0 ± 2.4 mV (n=4) 2: 
-25.2 ± 1.6 mV (n=6), 3: -18.7 ± 1.1 mV (n=6) SH3: -20.9 ± 1.1 mV (n=5) PDZ: and -19.6 ± 
2.5 mV (n=7) p=0.32, Figure 3D).  Consequently, the truncations and amino-acid replacements 
did not modify the biophysical characteristics of the channels.  
Interaction of Kv1.3 with cortactin  
We used Proximity Ligation Assay (PLA) to learn whether cortactin and Kv1.3 channels interact 
in HEK-293 cells and which portion of the channel protein is important for this association. This 
method enables detecting the interaction between proteins that reside at <40 nm distance through 
species-specific secondary antibodies each with unique short oligonucleotides and a polymerase 
that amplifies the circular DNA that is formed by hybridization when the two antibodies are in 
close proximity (Soderberg et al., 2006). The GFP antibody, which recognizes the EGFP moiety 
at the N terminus of the Kv1.3 channels, was used along with the cortactin antibody. As shown 
in Fig 4A, HEK-293 cells expressing wild-type EGFP-Kv1.3 clone display positivity for PLA 
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signal: red dots. The same experiments were performed for cells transfected with 1, 2, 3, 
SH3 Kv1.3 mutants. Confocal images were analyzed for number of dots and the results are 
summarized in Fig. 4B. The number of dots/cell in WT Kv1.3 is significantly different than in all 
the Kv1.3 mutants (p<0.001). Furthermore, the PLA signal in the 3 mutant is significantly 
higher than that in 1, 2 and SH3 mutants (p<0.001). These finding suggests that cortactin 
binds Kv1.3 in intact cells and that the association between these proteins occurs through the 
SH3-binding domain. Further PLA experiments confirmed the close proximity and interaction of 
cortactin with actin thus suggesting a role for cortactin in linking Kv1.3 to the actin cytoskeleton 
(Fig. 4C) (Daly, 2004). We then tested whether the lateral membrane motility of Kv1.3 depends 
on an active process that is mediated by actin and whether cortactin guarantees the association 
between Kv1.3 and actin. 
 
Lateral mobility of Kv1.3 channel constructs   
The lateral membrane motility of Kv1.3 and its dependence on the actin cytoskeleton and 
cortactin were established in (Fluorescence Recovery after Photobleaching) FRAP experiments. 
The recovery of fluorescence in the plasma membrane after photobleaching occurred by lateral 
membrane diffusion for all transfected Kv1.3 channels as can be seen by the time series of Kv1.3 
fluorescent recovery depicted in Figure 5A and, for WT Kv1.3, in a supplemental movie 
(Supplemental Movie 1). Analysis of FRAP recovery curves yielded an estimate of the mobile 
fraction (Mf) of Kv1.3 channels (Fig. 5A and B).  Alterations of Kv1.3 membrane mobility by 
actin polymerization were determined to establish the role that actin has on the channel motility. 
Where indicated jasplakinolide, which is a cyclic peptide of Jaspis johnstoni (a marine sponge), 
was applied for 50 min before FRAP experiments to induce actin polymerization and 
stabilization of the filaments (Bubb et al., 1994; Bubb et al., 2000). The addition of 
jasplakinolide caused a significant reduction in Mf in the WT, Δ3, and ΔPDZ mutants of 40-50% 
compared to cells that were not pre-treated with jasplakinolide, but jasplakinolide did not affect 
the Mf of Δ1, Δ2, and ΔSH3 mutants (Fig. 5). The average Mf of all channel mutants without 
jasplakinolide pre-treatment was 0.71 ± 0.01 (n=41, Fig. 5B).  The average Mf of WT, Δ3, and 
ΔPDZ channels treated with jasplakinolide was 0.43 ± 0.01 (n=18), while the average Mf of Δ1, 
Δ2, and ΔSH3 channels treated with jasplakinolide was 0.63 ± 0.01 (n=15). These outcomes 
support the importance of the SH3-binding domain in the functional interaction between the 
channel and actin cytoskeleton.   
 
Role of cortactin in Kv1.3 mobility 
FRAP experiments with mutant channels confirmed that cortactin and actin have a role in Kv1.3 
channel immobilization. Hence, we used another approach to test the role of cortactin: a HEK-
293 cell line with depleted cortactin level was established using lentiviral shRNA transduction. 
Figure 6A shows that cortactin expression was significantly reduced in cortactin-shRNA virus 
particle infected cells (control: non–target/scramble shRNA transduced cells).  As a next step we 
expressed EGFP-tagged wild-type Kv1.3 channels in these cells lines, and subjected them to 
FRAP experiments with or without jasplakinolide treatment (Fig. 6B). The Mf  of Kv1.3 channels 
in cortactin knock-down cells was the same regardless the pre-incubation with jasplakinolide or 
not (Mf : 0.61 ± 0.03 for control (n=5), and 0.50 ± 0.08 for jasplakinolide (n=5), p=0.43). On the 
contrary, the mobility of wild-type channels significantly dropped in control shRNA transduced 
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cells when actin stabilization was provoked by jasplakinolide (Mf: 0.66 ± 0.04 for control (n=4); 
and 0.41 ± 0.09 for jasplakinolide (n=4), p=0.033).   These studies further confirm the role of 
cortacin in the F-actin mediated lateral motility of Kv1.3. 
 
Interaction of Kv1.3 and HS1 in T lymphocytes  
The studies reported so far demonstrated that an association exists between recombinant Kv1.3 
channels and cortactin in HEK-293 cells. Further immunohistochemistry experiments in primary 
T cells showed that native Kv1.3 channels and HS1 (the cortactin analog expressed in T cells) 
co-localize at the IS (Fig. 7A). Primary human T cells were activated with beads coated with 
anti-CD3 and anti-CD28 antibodies (CD3/CD28 beads). These beads mimic APCs: they bind to 
the T cells, induce the formation of the IS and activate them (Nicolaou et al., 2007). Cells 
coupled with CD3/CD28 beads were stained for endogenous Kv1.3 (green) and HS1 (red). The 
merge image in Figure 7A shows co-localization of these two proteins at the bead/T cell contact 
point (the IS). The actual interaction between Kv1.3 and HS1 at the IS was established by PLA 
experiments in Jurkat T cells stably expressing GFP-tagged WT Kv1.3 channels (Fig. 7B-C). 
PLA positive signal was present at the IS where Kv1.3 accumulate (Supplemental Fig. 2). On the 
contrary, when PLA was performed on cells that expressed truncated C Kv1.3 channels (see 
also Fig. 2C), although these channels are recruited at the IS, they do not interact with HS1 as 
indicated by the significant drop in the PLA signal (Fig.7B-C). Similarly, WT Kv1.3 channels do 
not associate with HS1 in resting T cells, which were not exposed to CD3/CD28 beads (no IS). 
These data indicate that Kv1.3-HS1 interaction occurs only upon activation of T cells and is 
strictly happening at the IS. Furthermore they emphasize that HS1 in T lymphocytes, like 
cortactin in HEK-293 cells, interact with Kv1.3 via the carboxyl terminal of the channel.   
 
DISCUSSION  
As described by various groups, cortactin can bind to ion channels; however, the site of 
interaction is still unresolved. An extensive study performed by the workgroup of Morielli 
described the 19-amino acid span on the C-terminus of the Kv1.2 channel as an essential element 
in the channel’s coupling to cortactin (Williams et al., 2007; Cheng et al., 2011). Furthermore, 
this group also described that fusion of the SH3 binding domain with the truncated Kv1.2, which 
does not have the cortactin binding site, can partially restore the coupling of cortactin to the 
channel (Hattan et al., 2002; Williams et al., 2007). Surprisingly, the phosphorylation of tyrosine 
residues upstream of the cortactin binding domain of Kv1.2 abolished the interaction between the 
channel and cortactin (Hattan et al., 2002; Williams et al., 2007). Others showed that cortactin 
binds directly to the SH3-binding domains of the C terminal region of ENaC (epithelial sodium 
channel) and BKCa (large conductance Ca
2+
-activated K) channels, without any adaptor proteins 
(Tian et al., 2006; Ilatovskaya et al., 2011). Here we demonstrated by means of the PLA that in 
an intact cell, the interaction between cortactin and Kv1.3 channels exclusively occurs through 
the SH3 domain, and the other potential binding sequences of the Kv1.3 have hardly any 
influence on this coupling. These data indicate that other cortactin-binding sites existing on the 
Kv1.3 protein are unavailable in an intact cell setting where they may be masked by post-
translational modifications and/or the presence of other proteins that compete for those sites. 
Experiments with the PDZ mutant showed that disruption of the PDZ-binding domain did not 
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modify cortactin-channel binding, which confirms the direct coupling between Kv1.3 and 
cortactin. This is in agreement to what reported in the literature for other channels (Tian et al., 
2006; Ilatovskaya et al., 2011). Further PLA experiments verified that the Kv1.3-HS1 interaction 
in Jurkat T cells occurs via the C-terminus of the channel. Nevertheless, this coupling is not 
constitutive and triggered by TCR activation and intracellular mediators not yet known as the 
PLA positivity was only seen in the IS-engaged but not standalone T cells (Fig. 7). Overall, these 
results point to the existence of a physical association between cortactin (and HS1) and Kv1.3, 
and its possible role in cytoskeleton-regulated functions.  
The functional studies reported herein discovered a role for actin and cortactin in Kv1.3 
membrane motility. The FRAP studies revealed that actin polymerization/remodeling induced by 
jasplakinolide can lead to a significant decrease in Mf of Kv1.3 channels, which were described 
to ramble more-or-less freely in the plasma membrane (O'Connell and Tamkun, 2005). Herein 
we provide evidence for a role of the actin cytoskeleton in locking Kv1.3 and limiting its 
diffusion in the plasma membrane. Binding of PDZ proteins to Kv channels was shown to induce 
clustering of Kv1.3, Kv1.4, and Kv1.5 channels into cell surface domains and reduce Kv1.5 cell 
membrane mobility (Imamura et al., 2002; Marks and Fadool, 2007). In our studies, PDZ-
domain adaptor proteins such as hDlg and PSD-95 were excluded as regulators of Kv1.3 
membrane motility (the Mf  of the PDZ mutant before actin polymerization is equivalent to that 
of WT channels) and as linkers of the cortical cytoskeleton and Kv1.3. Mutating the PDZ-
binding domain (ΔPDZ) we could observe the same immobilization of the channels upon 
jasplakinolide treatment like it was observed in WT Kv1.3. Both Δ1  and Δ2 mutants instead 
showed no significant “arrest” by the induction of actin polymerization (Fig. 5), indicating that 
the putative cortactin-binding site is insufficient to provide a functional attachment of Kv1.3 to 
the cytoskeleton. Upon “re-addition” of SH3-binding site (Δ3) the drop in Mf after actin-
polymerization was comparable to that of wild-type channels. Conversely, mutation of the SH3-
binding motif (ΔSH3) cancelled the channel’s immobilization by jasplakinolide. Overall, these 
data support a model in which the interaction between cortactin and Kv1.3 has functional 
implications only when actin-remodeling is induced. When no actin-polymerization occurs, the 
channels presumably diffuse freely along the plane of the membrane but upon actin-
polymerization the channel-cortactin complex becomes trapped by the F-actin network. 
Consequently, the SH3-binding motif provides the interface for cortactin-Kv1.3 coupling as 
reported for ENac and BKCa, and confirmed by the PLA results.   
Cortactin has also been reported to regulate the surface expression of ion channels 
(Hattan et al., 2002; Williams et al., 2007; Cheng et al., 2011; Herrmann et al., 2012).  By patch-
clamping we found that all EGFP-tagged Kv1.3 mutant plasmids were expressed in HEK-293 
cells and could form conducting tetrameric channels. It has been described recently that two 
glutamic acids (E) at position 483 and 484 of Kv1.3 carboxyl terminus are the part of the cell 
membrane sorting sequence and aids forward trafficking (Martínez-Mármol et al., 2013). Here 
we observed that their removal in the Δ1 construct did not influence the detection of EGFP 
signal in the plasma membrane. Nevertheless, we cannot exclude that Δ1 truncation leads to a 
lower expression level in the whole-cell configuration (here we used outside-out patches), and 
that assembly with endogenous Kv1.3 subunits in HEK-293 steered the heteromeric channels to 
the plasma membrane. We must note that for our ∆C mutant we did not obtain different 
expression level in Jurkat T cells as compared to the wild-type Kv1.3 (Szilagyi et al., 2013). 
Hence, we extrapolate the same to be true for all Kv1.3 constructs tested here. As the channels 
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were overexpressed in HEK-293 cells a possible reduction in the mutant channel’s targeting to 
the membrane had no impact on the measurement of Kv1.3 diffusion as indicated by the similar 
values of baseline Mf (before jasplakinolide addition). 
 Finally, knock-down of cortactin clearly demonstrated that assemblage of F-actin with 
Kv1.3 channels is mediated by cortactin upon jasplakinolide stimulation. Wild-type Kv1.3 
channels expressed in cortactin-silenced cells did not show immobilization by jasplakinolide 
treatment unlike channels transfected into scramble shRNA-treated cell line (Fig. 6B). Due to the 
elimination of the linker element, Kv1.3 channels are not affixed to the cytoskeleton and, upon 
actin remodeling, can freely move in the plasma membrane. Hence, cortactin has a pivotal role in 
the anchoring of Kv1.3 channels.  
In this study we could show that the pore-forming alpha subunit of another potassium ion 
channel is coupled to the cortical actin network, which stabilizes it upon F-actin nucleation. 
Since Kv1.3 channels are part of molecular machinery required for activation of T cells, our 
results may provide new insights into the mechanisms that control Kv1.3 membrane localization 
in the IS which is of great importance in T cell function. The PLA experiments in T cells showed 
that the lack of a HS1-binding site does not preclude the channel from entering the IS, suggesting 
that HS1 may not affect Kv1.3 diffusion into the IS.  Therefore, it is possible that HS1 may alter 
the time Kv1.3 resides in the IS or its association with signaling molecules also residing at the IS 
that ultimately control its activity (Nicolaou et al., 2010; Kuras et al., 2012). However, these 
hypotheses should be tested to understand functional significance of HS1-Kv1.3 interaction in T 
cells. Overall, the results presented herein raise the possibility that the association between HS1 
and Kv1.3 channels may shape the outcome of the signaling pathways during T cell activation.  
 
MATERIALS AND METHODS 
Kv1.3 channel constructs  
Plasmids (pEGFP-C1 backbone, Clontech) containing EGFP tagged wild-type (WT) and mutant 
Kv1.3 channels were generated for expression in human embryonic kidney (HEK-293) cells. 
EGFP attachment to the N-terminus of Kv1.3 constructs was performed as previously described 
(Nicolaou et al., 2010).  C-terminal Kv1.3 mutants were generated by either amino acid sequence 
truncations or specific amino acid mutagenesis. Truncated C-terminal Kv1.3 mutants were 
created by insertion of a premature stop codon into the Kv1.3 DNA sequence prior to the 
specified truncation site.  Truncation sites were specified just prior to the presumed cortactin 
binding site at amino acid 466 (Δ1 mutant), after the presumed cortactin binding site at amino 
acid 487 (Δ2 mutant), and after an SH3 binding motif (-P-x-x-P-) at amino acid 496 (Δ3).  
Presumed cortactin binding site of Kv1.3 was determined from analogous amino acid sequence 
in Kv1.2 (Hattan et al., 2002).  A C-terminal mutant with altered SH3 binding motif (ΔSH3) was 
generated by changing proline residues at amino acids 493 and 496 to glycines, and a C-terminal 
mutant with altered PDZ binding domain (ΔPDZ) was generated by changing the amino acid 
sequence FTDV at the end of the C-terminus to WSGG. Plasmid for the ΔSH3 mutant was a gift 
from Dr. Fadool (Florida State University) and has been previously described (Marks and 
Fadool, 2007). A schema of Kv1.3 wild type and C-terminal mutants can be found in Figure 2. 
We generated a construct for rat Kv1.3 containing a FLAG tag between D222 and V223 in the 
extracellular loop between S1 and S2 transmembrane domains.  Briefly, a DNA fragment 
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containing the nucleotide sequence corresponding to a FLAG tag (YKDDDDK) was generated 
by two-step overlapped PCR.  The generated fragment was replaced with the corresponding 
portion of Kv1.3 cDNA using SphI and PstI sites.  The sequence of the PCR amplified portion 
was verified by DNA sequencing. 
 
Cell culture and transfection 
HEK-293 cells were cultured in DMEM media (Fisher Scientific) supplemented with 10% fetal 
bovine serum, 1 mM  Na-pyruvate,  200 unit penicillin/streptomycin (HEK-293 medium). HEK-
293 cells stably expressing FLAG tagged Kv1.3 channels or host plasmid (pcDNA3.1) were also 
grown in HEK-293 medium containing 1 mg/ml G418 (Sigma-Aldrich).  Transfections of DNA 
plasmids were done using Lipofectamine 2000
TM
 (Life Technologies) according to the 
manufacturer’s protocol. For cortactin knockdown experiments HEK-293 cells were transduced 
with lentiviral-based shRNA virus particles produced at the Lenti-shRNA Library Core, 
Cincinnati Children’s Hospital (www.cincinnatichildrens.org/research/cores/lenti/). The protocol 
for viral infection and cell culturing (puromycin selection) is available at 
www.cincinnatichildrens.org/research/cores/lenti/background-protocol/. Briefly, HEK-293 cells 
were plated 24 hours prior to lentiviral transduction in DMEM medium. Next day the medium 
was replaced with fresh DMEM medium containing 10 µg/ml polybrene (Sigma-Aldrich) and 
lentiviral supernatant which contained virus particles with cortactin or negative control shRNAs 
(Mission shRNA, Sigma-Aldrich). Non-target shRNA containing virus particles were used as 
negative control.  Knockdown cells were selected with 1-2 g/ml puromycin (Sigma-Aldrich). 
The efficiency of knock-down was monitored with Western blot technique. 
 
Primary T and Jurkat cells 
Human T cells were isolated from the blood of healthy consenting donors and discarded blood 
units from Hoxworth Blood Center (UC, Cincinnati) using RosetteSep
TM
 Human Total 
Lymphocyte Enrichment Cocktail (StemCell Technologies). The protocol was approved by 
University of Cincinnati IRB. T cells were maintained in RPMI-1640 medium supplemented 
with 10% human serum, 200 U/ml penicillin, 200 µg/ml streptomycin and 10 mM HEPES (T 
cell medium). Jurkat E6-1 cells were maintained in RPMI-1640 medium with 10% human 
serum, 200 U/ml penicillin, 200 µg/ml streptomycin 10 mM HEPES and passed every other day. 




HEK-293 cells transfected with various Kv1.3 channel constructs were washed with standard 
bath solution (composition was in mM: 145 NaCl, 5 KCl, 1 MgCl2, 2.5 CaCl2, 5.5 glucose, 10 
HEPES), and plated onto poly-L-lysine coated glass coverslips. Kv1.3 currents were recorded in 
outside-out configuration using Axopatch 200B amplifier (Axon Instruments, Foster City, CA, 
USA) as previously described (Szigligeti et al., 2006).  The pipette solution contained (in mM):  
140 KF, 11 K2EGTA, 1 CaCl2, 2 MgCl2, and 10 HEPES (pH 7.20, ~295 mOsm). P/5 protocol for 
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online leaks subtraction was applied to minimize capacitance and leak errors during the 
determination of the activation kinetics. 
The inactivation kinetics of each construct was determined upon fitting a single exponential 
function (I(t) = I0  exp(-t/i) + C, I0: amplitude of current, i: inactivation time constant, C: 
steady-state value of whole-cell current at the end of the pulse) to the decaying part of the traces 
evoked by 2-s-long depolarization to +40 mV from a holding potential (HP) of 120 mV.  
The voltage-dependence of steady-state activation was determined as detailed below. The 
outside-out patches were clamped at 120 mV HP and depolarizing test potentials from 70 up 
to +50 mV were in 10 mV steps delivered every 30 s. Peak conductance (G(V)) at each test 
potential was calculated from the peak current (Ip) at test potential (V) and the K
+
 reversal 
potential (Er=85 mV) with the equation G(V)=Ip/(V-Er).  The G(V) values were normalized for 
the maximum conductance and plotted against the test potential. Boltzmann-function was fitted 
to the data points:  GN = 1/(1+exp [ (VV½)/k], where GN is the normalized conductance, V is 
the test potential, V½  is the midpoint and k is the slope of the function. 
 
Immunocytochemistry 
HEK-293 cells stably expressing FLAG-Kv1.3 encoding plasmid or empty vector (pcDNA3.1, 
Life Technologies) were plated onto poly-L-lysine coverslips and incubated for 3-4 hrs (37 C, 
humidified, 5 % CO2). Then cells were fixed with 1% formaldehyde, and labeled with rabbit 
anti-FLAG antibody (10 µg/ml, Sigma-Aldrich Ltd.) overnight at 4 C. Afterwards cells were 
permabilized with 0.2% Triton-X 100 for 20 min at room temperature, and mouse anti-cortactin 
antibody (1:50 dilution; Santa-Cruz) was added overnight at 4 C. Secondary antibodies (donkey 
anti-rabbit with Alexa488, goat anti-mouse with Alexa647, Life Technologies) were added to the 
cells for 1 hour at room temperature. Finally coverslips were mounted onto slides with 
Fluoromount G (eBioScience). Zeiss LSM 510 META microscope was used to take confocal 
images of the cells (63× oil immersion lens, NA 1.4). The He-Ne laser was selected to excite 
fluorophore Alexa647 (line 633 nm) and Argon laser (line 488 nm) to visualize Alexa488. The 
thickness of the slices and z-stacks were set to 1 µm.  
Immunological synapse were formed between either resting T lymphocytes or  Jurkat T cells and 
anti-CD3/anti-CD28 antibody (CD3/CD28) coated polystyrene beads (Life Technologies) as 
detailed earlier (Nicolaou et al., 2007). Cell-bead conjugates were fixed 5 and 30 min after 
synapse formation and labelled with rabbit anti-Kv1.3 antibody (Alomone, Israel) at 4 C 
overnight. Then the cells were permeabilized as described for HEK-293 cells and goat anti-HS1 
antibody (R&D Systems, USA) was added. The secondary antibodies (goat anti rabbit IgG A488, 
donkey anti goat A647, Life Technologies) were incubated for 1 hour at room temperature. 
Afterwards coverslips were mounted onto slides with Fluoromount G. The confocal snapshots 
were taken as described above.   
 
Western blotting 
For shRNA experiments, transfected HEK-293 cells were lysed  using Pierce
®
 IP Lysis Buffer 
along with HALT Protease Inhibitor
TM
 cocktail (ThermoFisher Scientific) as previously 
described (Chimote et al., 2012). The protein content of the lysates was measured using the BCA 
Protein Assay (ThermoFisher Scientific). Cell lysates were mixed with 3X SDS sample buffer 
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(New England Biolabs) and 20 g of protein was loaded on to each lane of a 4-12% TRIS-
glycine gel (Life Technologies) in a X Cell SureLock
TM
 Gel System (Life Technologies). The 
protein bands were transferred to a PVDF membrane (Life Technologies) in a X Cell II Blot 
Module (Life Technologies). The membrane was blocked with Odyssey Blocking buffer (Licor 
Biosciences) at room temperature for 1 h and subsequently incubated overnight at 4 C with a 
polyclonal rabbit antibody against cortactin (SantaCruz Biotechnology Inc) along with a mouse 
monoclonal antibody against β-actin (Alpha Diagnostic International). The blot was thoroughly 
washed with PBS-T and incubated with Alexa Fluor 680 anti-rabbit and IRDye 800CW anti-
mouse secondary antibodies for 60 min at room temperature (Life Technologies). The blots were 
then visualized with the LI-COR Odyssey
®
 infrared scanner at 169µm resolution. 
  
Proximity ligation assay  
Proximity ligation assay (PLA) experiments were performed using Duolink
®
 In Situ PLA
®
 Kit 
(Sigma-Aldrich) with Detection Reagents Red as suggested by the manufacturer’s protocol.  
HEK-293 cells were transfected with EGFP-tagged Kv1.3 constructs, then plated onto poly-L-
lysine coated coverslips. Primary antibodies were mouse anti-GFP (1:200, Miltenyi Biotec) and 
rabbit anti-cortactin (1:200, Santa-Cruz Biotechnology Inc.). Jurkat cells stably expressing GFP-
WT or C Kv1.3 channels were incubated with CD3/CD28 beads for 30 min, plated on poly-l-
lysine coated coverslips. Cells incubated without the beads were used as controls (resting, no IS, 
T cells). Cells were fixed permeabilized and then incubated with mouse anti-GFP (1:200, 
Miltenyi Biotec) and goat anti-HS1 (1:200, R&D systems).  Confocal images were taken with a 
Zeiss LSM 710 microscope with 63× water immersion lens (pinhole was set to 1 Airy unit). 
Individual interacting molecule pairs are detected as bright fluorescent spots. Evaluation of PLA 
snapshots was done by the Duolink Image Tool software (demo version) which allows 
quantitating the PLA signal.  
 
Fluorescence recovery after photobleaching (FRAP)  
Transfected HEK-293 cells were plated onto collagen and poly-L-lysine coated glass coverslips 
and incubated in DMEM without phenol red at 37 C for at least 1 hour before performing FRAP 
experiments.  Cells were also bathed in DMEM without phenol red during FRAP measurements.  
A subset of cell coverslips was also bathed in a solution containing the actin polymerizing agent 
jasplakinolide (Calbiochem) (2 µM; DMSO 1:1000 dilution in control cells) for 50 minutes at 37 
C prior to FRAP measurements. FRAP experiments were performed on a Zeiss LSM 510 Meta 
confocal microscope with a 40× water immersion objective (NA 1.2) at room temperature.  
Pinhole size was set between 0.8-0.86 µm (slice thickness was approximately 1 µm).  During the 
measurements EGFP-tagged Kv1.3 channels were excited with a 488 nm Argon laser that was 
passed through an EGFP-filter of 505-535 nm at 1% power for pre- and post-bleach 
measurements. Photobleaching was confined to a region of interest (ROI) only along the cell 
membrane and was performed with the Argon laser (488 nm) at 100% power for 100 bleach 
iterations over this ROI. Confocal images during FRAP experiments were acquired every 15 
seconds at a resolution of 512x512 and 3x zoom for a total of 60 scans.  The background 
fluorescence was subtracted from the average fluorescent intensity over the photobleached ROI 
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from each image and then normalized to the pre-bleach intensity.  These normalized values were 










                         (1) 
where F∞ is the fluorescence at the end of the FRAP experiments, F0  is the fluorescence 
intensity immediately post-bleach, and Fi is the fluorescence pre-bleach.   
 
Statistical analysis 
Data are expressed as the mean ± standard error.  Means were compared using Student’s t-test, 
One-Way ANOVA and One-Way ANOVA on Ranks.  P-values <0.05 were considered 
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Figure 1. Kv1.3 channels co-localize with cortactin. Confocal images of 1 µm thickness of two 
representative FLAG-Kv1.3 expressing HEK-293 cells labeled with FLAG and cortactin 
antibodies. Panels show: a: brightfield image of the cell, b: Kv1.3 (green), c: cortactin (red), d: 
overlay of red and green channels. Note that overlapping of the red and the green signal turns 





Figure 2. Scheme of wild-type Kv1.3 channel and C-terminal mutations.  A) Alignment of 
Kv1.2 cortactin-binding site to Kv1.3 C-terminus. B) Schematic representation of wild type 
(WT) Kv1.3 pore-forming alpha subunit with EGFP tag, cortactin-, SH3-, and PDZ-binding 
regions. c)  Amino acid sequences of WT Kv1.3 and mutant Kv1.3 C-terminuses starting at 
amino acid 431.  ΔC truncation removes the entire C-terminus except HRET sequence needed 
for membrane targeting. Δ1 mutation represents truncation of Kv1.3 C-terminus before the 
predicted cortactin-binding site. Δ2 mutant represents truncation of Kv1.3 C-terminus directly 
after the putative cortactin binding site. Δ3 mutant represents mutation of Kv1.3 C-terminus 
directly after SH3 binding site. ΔSH3 mutant represents an amino acid sequence change from 
PQTP to GQTG. ΔPDZ mutant represents an amino acid sequence change from FTDV to 





Figure 3. Biophysical characterization of Kv1.3 constructs. A) To determine the inactivation 
kinetics of the currents outside-out patches were depolarized to +40 mV for 2 seconds from a HP 
of -120 mV. Typical current records for the EGFP-tagged WT and Δ1 construct are shown. B) 
Average inactivation time constant (i) for various Kv1.3 mutants. C) Voltage-dependence of 
steady-state activation of the Kv1.3 channels in HEK-293 cells, outside-out configuration. The 
normalized conductance-test potential relationships were recorded and evaluated as detailed in 
the Materials and Methods. Normalized conductance as a function of the test potential for WT 
(filled circles) and Δ1 (empty triangles) along with fitted Boltzmann-function (solid lines) are 
plotted for two actual patches. D) Parameters of steady-state activation (slope, k, and midpoint, 





Figure 4. Cortactin and Kv1.3 channel interaction in HEK-293 cells. (A)  PLA experiments 
performed with wild-type, EGFP-Kv1.3-transfected HEK-293 cells. Top row: negative control, 
only secondary antibodies were added, bottom row: both primary (anti-GFP and anti-cortactin) 
and secondary antibodies were used. Single protein interactions are visualized as fluorescent red 
dots.  (B) Box plot of number of PLA dots per cell. The data are reported as median, first (top 
box) and third quartiles (bottom box), and maximum and minimum of 93 cells for WT,  44 for 
1, 34 for 2, 60 for 3 and 78 for SH3. All the groups are significantly different from each 
other (p<0.001) except SH3 vs 2. (C) Interaction between actin and cortactin in HEK-293 
cells. HEK-293 cells were labeled with (top row) or without (bottom row, only PLA antibodies) 
rabbit anti-human cortactin and mouse anti-human actin antibodies, then PLA probe-ligated 
secondary antibodies were added and PLA was performed according to the manufacturer’s 





Figure 5. FRAP recovery curves of Kv1.3 wild type and mutant channels.  A) Each panel 
depicts the percent of fluorescent signal recovery at each time point averaged over all FRAP 
experiments for each respective Kv1.3 channel type in HEK-293 cells.  Curves depicted include 
experiments both without jasplakinolide pre-treatment of HEK-293 cells () and with 
jasplakinolide pre-treatment (○).  Error bars represent the standard error of these averages at each 
time point (n was without/with jasplakinolide: 7/7 for WT, 6/6 for 1, 7/3 for 2, 7/7 3, 6/6 for 
SH3 and 8/4 for PDZ: ).  B) Average mobile fraction (Mf) for each individual mutant and WT 
Kv1.3. Mf differences with p-values < 0.05 between trials with and without jasplakinolide pre-





Figure 6. Cortactin knock-down annuls the effect of jasplakinolide. A) Westen blot of total 
cell lysates of HEK-293 cells transduced with cortactin or scramble shRNA virus particles using 
cortactin antibody (1,2: scramble shRNA; 3,4: cortactin shRNA, 5: non-transduced HEK-293).  
20 ug of protein lysate was loaded in each lane and the transferred proteins were probed with 
rabbit anti-cortactin antibody, whereas mouse anti--actin was used as a loading control. B) 
Averaged FRAP recovery curves of Kv1.3 wild type channel in cortactin altered HEK-293 cells.  
Each panel depicts the percent of fluorescent signal recovery at each time point averaged over all 
FRAP experiments for wild-type Kv1.3 channels with or without cortactin knockdown. Plotted 
curves include experiments both without jasplakinolide pre-treatment () and with jasplakinolide 
pre-treatment (○).  Error bars represent the standard error of these averages at each time point (n 
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= 4-5).  Mobile fraction differences with p-values < 0.05 between trials with and without 





Figure 7. HS1 and Kv1.3 interact at the immunological synapse. B)  Micrographs (1 µm slice 
size) of human primary T cells forming immunological synapses (denoted with an asterisk in 
panel c) with CD3/CD28 bead at 30 min. Panels show: a) brightfield, b) Kv1.3 (green), c) HS1 
(red), d) merge of green and red channels. The yellow color denotes co-localization of Kv1.3 and 
HS1. B) Confocal images of representative cells from PLA experiments performed in Jurkat cells 
stably expressing wild-type mGFP-Kv1.3 channels (WT, top row) and mGFP-Kv1.3 channels 
with a C terminal truncation (C, middle row) forming immunological synapses with CD3/CD28 
beads at 30 min. Jurkat cells overexpressing WT mGFP-Kv1.3 without beads (no IS) are shown 
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in the, bottom row. Single protein interactions are visualized as red fluorescence dots.  (B) 
Average PLA signals. PLA signals were quantified in cells as number of dots/cell and are 
represented as mean ± SEM for 53 cells for WT, 86 for C and 91 for resting, “no IS”, cells. 
Statistically significant difference was observed in WT vs C and WT vs “no IS" groups (p < 













Supplemental Information 1: Immunoprecipitation of Kv1.3 and Dlg-1. HEK-293 cells were 
transiently transfected by Lipofectamine-2000 (Invitrogen Corp.Life Technologies) with either 
EGFP-tagged WT Kv1.3 or PDZ and myc-Dlg1 (gift of R.J. Xavier, Harvard Medical School, 
Boston) plasmid DNAs.  Total cell lysate was prepared as previously described (Szigligeti et al., 
2006). After centrifugation for 10 min at 1400 rpm at 40°C, the cell pellet was lysed with Pierce® 
IP lysis buffer (Pierce ThermoFisher Scientific) and sonicated for 30 sec. After centrifugation for 
10 min at @ 14000rpm and at 4°C, the supernatant was pre-cleared with protein G sepharose 
beads (Upstate Biotechnology) for 1 hour at 4° C.  Beads were removed by centrifugation @ 
14000 rpm for 10 min at 4° C and protein content in the supernatant was measured using the 
Pierce BCA Protein Assay (Thermo Fisher Scientific). Immunoprecipitation was performed for 
myc-Dlg1 with Pierce c-Myc Tag IP/Co-IP Kit (ThermoFisher Scientific) according to 
manufacturer’s instructions. 600 g of the pre-cleared lysate was immunoprecipitated by 
overnight incubation with 10 l pre-washed anti-c-Myc agarose slurry (5 g anti-c-Myc 
antibody).  Protein G agarose beads were used as negative control. Beads were thoroughly 
washed and proteins were eluted from the resin/beads by boiling for 5 min in SDS sample buffer. 
Western blotting was performed on the eluted proteins as described in  Materials and Methods 
and the proteins were probed with mouse anti-c-Myc (1:800 fold, Covance) and rabbit anti-GFP 
(1: 100 fold, Santa Cruz Biotechnology Inc) primary antibodies and Alexa Fluor 680 anti-rabbit 
and IRDye 800CW anti-mouse secondary antibodies. The blots were subsequently visualized on 
LI-COR Odyssey® infrared scanner and analyzed using Odyssey v3.0 software as described 
earlier. 
Supplemental Information 2: Immunological Synapse Quantification. Experiments were 
conducted to establish that an IS with Kv1.3 accumulation was formed at the T cell-beads point 
of contacts. Confocal images obtained for Jurkat T cells in PLA experiments were quantitated for 
GFP fluorescence in the presence or absence of CD3/CD28 beads using Image J. Using the line 
selection tool, lines were drawn either in the region of contact between an individual cell and 
beads or along the cell membrane, not in contact with the beads (resting, “No IS”). GFP 
fluorescence was measured using the “Plot Profile” tool. The peak green fluorescence intensity 
was comparable in WT and C Kv1.3-expressing cells and significantly higher than resting (no 
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type mGFP Kv1.3 channels incubated without the beads (no IS) are shown in C. GFP 
fluorescence was quantified along a line drawn either in the region of contact with the beads or 
randomly along the plasma membrane for resting (no bead/no IS) cells (shown in the brightfield 
image) and the values of the corresponding GFP fluorescence are shown in the right panels. (D) 
Average peak mGFP fluorescence for 31 cells for WT, 23 cells for C and 27 cells for “no IS”  
(p<0.001).  
 
 
